circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2

Table 1 Association between circCUL2 expression and clinicopathological characteristics in gastric cancer

Characteristics	n	High expression	Low expression	P
Gender
Female	32	14	18	0.8862
Male	68	36	32
Age(y)
≤ 60	41	17	24	0.8529
> 60	59	33	26
Tumor size (cm)
≥ 3	65	34	31	0.8437
< 3	35	16	19
Histological type
Well differentiated	39	28	11	< 0.001***
Poorly differentiated	61	22	39
Clinical stage
I-II	37	22	15	< 0.001***
III-IV	63	28	35
Tumor depth
T1-T2	23	10	13	0.6132
T3-T4	77	40	37
Lymph node metastasis
No	19	13	6	< 0.001***
Yes	81	37	44
Lauren classification
Intestinal	49	27	22	0.6275
Diffuse	21	12	9
Uncertain	30	11	19
Helicobacter Pylori
Positive	22	5	17	0.0524
Negative	41	22	19
Uncertain	37	23	14

ISSN: 1476-4598